ClearLight Diagnostics licenses IP rights for tissue processing and imaging technologies

Sept. 18, 2015

ClearLight Diagnostics has signed a license agreement for the rights covering inventions relating to tissue imaging and processing.

BioOptics World Editors

ClearLight Diagnostics (Sunnyvale, CA), which develops tools and technologies for analyzing and imaging tissue samples, has signed an exclusive, worldwide license agreement with Stanford University (CA) for the intellectual property rights covering inventions relating to tissue imaging and processing.

The licensed technologies involve CLARITY, a tissue transparentizing method, and CLARITY Optimized Light-sheet Microscopy (COLM), a new optics system for accelerating image collection from clarified samples.

ClearLight is initially funded by a syndicate created by Wiegers Capital Partners LLC, and plans to commercialize products and services based on the licensed technologies.

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)